STAT3 and lung adenocarcinoma: For instance, STAT3 activity has been observed to be inhibited through Erk1/2- and p38-dependent pathways in human lung adenocarcinoma, while JNK inhibition reduces STAT3 serine phosphorylation in oral squamous cell carcinoma [55,56].